Letter to Shareholders re: Terms of Upcoming Non-Renounceable Entitlement Issue
Prospectus, Licence Valuation and Appointment of CEO
Chairman & CEO Address & Presentation at AGM
Notice of Annual General Meeting
Changes to Distribution of Annual Reports
Grant of Key VIR201 Patent in Europe
Receipt of A$1m in Milestone Payments from Transgene
Publication of VIR201 Phase IIa Trial Results in peer reviewed scientific journal
Allowance of Key VIR201 Patent in the USA
Virax to Receive Milestone Payment from Transgene
Virax to Receive Milestone Payment from Transgene
Virax Grants License to Transgene